555 related articles for article (PubMed ID: 28770966)
1. Inhibition of miR-221 influences bladder cancer cell proliferation and apoptosis.
Liu H; Chang JK; Hou JQ; Zhao ZH; Zhang LD
Eur Rev Med Pharmacol Sci; 2017 Jul; 21(14):3193-3199. PubMed ID: 28770966
[TBL] [Abstract][Full Text] [Related]
2. MiR-155 regulates lymphoma cell proliferation and apoptosis through targeting SOCS3/JAK-STAT3 signaling pathway.
Li XD; Li XM; Gu JW; Sun XC
Eur Rev Med Pharmacol Sci; 2017 Nov; 21(22):5153-5159. PubMed ID: 29228427
[TBL] [Abstract][Full Text] [Related]
3. MiR-340 affects gastric cancer cell proliferation, cycle, and apoptosis through regulating SOCS3/JAK-STAT signaling pathway.
Xiao C; Hong H; Yu H; Yuan J; Guo C; Cao H; Li W
Immunopharmacol Immunotoxicol; 2018 Aug; 40(4):278-283. PubMed ID: 29658372
[TBL] [Abstract][Full Text] [Related]
4. SOCS3 overexpression enhances ADM resistance in bladder cancer T24 cells.
Li MZ; Lai DH; Zhao HB; Chen Z; Huang QX; Situ J
Eur Rev Med Pharmacol Sci; 2017 Jul; 21(13):3005-3011. PubMed ID: 28742207
[TBL] [Abstract][Full Text] [Related]
5. MiR-203 regulates JAK-STAT pathway in affecting pancreatic cancer cells proliferation and apoptosis by targeting SOCS3.
Lin XM; Chen H; Zhan XL
Eur Rev Med Pharmacol Sci; 2019 Aug; 23(16):6906-6913. PubMed ID: 31486490
[TBL] [Abstract][Full Text] [Related]
6. MiR-101 promotes nasopharyngeal carcinoma cell apoptosis through inhibiting Ras/Raf/MEK/ERK signaling pathway.
Wu RS; Qiu EH; Zhu JJ; Wang JR; Lin HL
Eur Rev Med Pharmacol Sci; 2018 Jan; 22(1):150-157. PubMed ID: 29364482
[TBL] [Abstract][Full Text] [Related]
7. MiR-410 affects the proliferation and apoptosis of lung cancer A549 cells through regulation of SOCS3/JAK-STAT signaling pathway.
Li M; Zheng R; Yuan FL
Eur Rev Med Pharmacol Sci; 2018 Sep; 22(18):5987-5993. PubMed ID: 30280781
[TBL] [Abstract][Full Text] [Related]
8. MiR-17 Regulates Prostate Cancer Cell Proliferation and Apoptosis Through Inhibiting JAK-STAT3 Signaling Pathway.
Dai H; Wang C; Yu Z; He D; Yu K; Liu Y; Wang S
Cancer Biother Radiopharm; 2018 Apr; 33(3):103-109. PubMed ID: 29641255
[TBL] [Abstract][Full Text] [Related]
9. The effect of miR-224 down-regulation on SW80 cell proliferation and apoptosis and weakening of ADM drug resistance.
Liang CQ; Fu YM; Liu ZY; Xing BR; Jin Y; Huang JL
Eur Rev Med Pharmacol Sci; 2017 Nov; 21(21):5008-5016. PubMed ID: 29164556
[TBL] [Abstract][Full Text] [Related]
10. MiR-203 regulates proliferation and apoptosis of ovarian cancer cells by targeting SOCS3.
Liu HP; Zhang Y; Liu ZT; Qi H; Zheng XM; Qi LH; Wang JY
Eur Rev Med Pharmacol Sci; 2019 Nov; 23(21):9286-9294. PubMed ID: 31773696
[TBL] [Abstract][Full Text] [Related]
11. In vivo and in vitro effects of microRNA-221 on hepatocellular carcinoma development and progression through the JAK-STAT3 signaling pathway by targeting SOCS3.
Huang S; Zhou D; Li YX; Ming ZY; Li KZ; Wu GB; Chen C; Zhao YN
J Cell Physiol; 2019 Apr; 234(4):3500-3514. PubMed ID: 30370582
[TBL] [Abstract][Full Text] [Related]
12. MiR-182 affects renal cancer cell proliferation, apoptosis, and invasion by regulating PI3K/AKT/mTOR signaling pathway.
Fu JH; Yang S; Nan CJ; Zhou CC; Lu DQ; Li S; Mu HQ
Eur Rev Med Pharmacol Sci; 2018 Jan; 22(2):351-357. PubMed ID: 29424922
[TBL] [Abstract][Full Text] [Related]
13. Targeting of GSK-3β by miR-214 to facilitate gastric cancer cell proliferation and decrease of cell apoptosis.
Li HL; Liang S; Cui JH; Han GY
Eur Rev Med Pharmacol Sci; 2018 Jan; 22(1):127-134. PubMed ID: 29364479
[TBL] [Abstract][Full Text] [Related]
14. MiR-20a regulates fibroblast-like synoviocyte proliferation and apoptosis in rheumatoid arthritis.
Wei XJ; Li XW; Lu JL; Long ZX; Liang JQ; Wei SB; Lu CX; Lu WZ
Eur Rev Med Pharmacol Sci; 2017 Oct; 21(17):3886-3893. PubMed ID: 28975975
[TBL] [Abstract][Full Text] [Related]
15. CircularRNA-9119 protects hepatocellular carcinoma cells from apoptosis by intercepting miR-26a/JAK1/STAT3 signaling.
Yang L; Xue H; Sun Y; Zhang L; Xue F; Ge R
Cell Death Dis; 2020 Jul; 11(7):605. PubMed ID: 32732872
[TBL] [Abstract][Full Text] [Related]
16. MiR-221 inhibits proliferation of pancreatic cancer cells via down regulation of SOCS3.
Xie J; Wen JT; Xue XJ; Zhang KP; Wang XZ; Cheng HH
Eur Rev Med Pharmacol Sci; 2018 Apr; 22(7):1914-1921. PubMed ID: 29687843
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-520a-3p suppresses epithelial-mesenchymal transition, invasion, and migration of papillary thyroid carcinoma cells via the JAK1-mediated JAK/STAT signaling pathway.
Bi CL; Zhang YQ; Li B; Guo M; Fu YL
J Cell Physiol; 2019 Apr; 234(4):4054-4067. PubMed ID: 30206929
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-204 targets JAK2 in breast cancer and induces cell apoptosis through the STAT3/BCl-2/survivin pathway.
Wang X; Qiu W; Zhang G; Xu S; Gao Q; Yang Z
Int J Clin Exp Pathol; 2015; 8(5):5017-25. PubMed ID: 26191195
[TBL] [Abstract][Full Text] [Related]
19. MiR-155 regulates the proliferation and apoptosis of pancreatic cancer cells through targeting SOCS3.
Wang J; Guo J; Fan H
Eur Rev Med Pharmacol Sci; 2019 Jun; 23(12):5168-5175. PubMed ID: 31298410
[TBL] [Abstract][Full Text] [Related]
20. MiR-155 affects renal carcinoma cell proliferation, invasion and apoptosis through regulating GSK-3β/β-catenin signaling pathway.
Wei RJ; Zhang CH; Yang WZ
Eur Rev Med Pharmacol Sci; 2017 Nov; 21(22):5034-5041. PubMed ID: 29228417
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
